/Johnson%20%26%20Johnson%20location%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
Headquartered in New Brunswick, New Jersey, Johnson & Johnson (JNJ) researches and develops, manufactures, and sells various products in the healthcare field. Valued at a market cap of $385.1 billion, the company boasts a broad portfolio of drugs covering a wide range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. It is expected to announce its fiscal Q1 earnings for 2025 before the market opens on Tuesday, Apr. 15.
Prior to this event, analysts project this healthcare giant to report a profit of $2.59 per share, down 4.4% from $2.71 per share in the year-ago quarter. The company has exceeded Wall Street's earnings estimates in each of the last four quarters. Its earnings of $2.04 per share in the previous quarter outpaced the consensus estimate by 2%.